Patience is key while Investing in equities. Build a diversified portfolio of small and mid caps by Investing in Hidden Gems and Value Picks. Click here for details.

SERVICES:        HIDDEN GEMS    |    VALUE PICKS    |    15% @ 90 DAYS    |    WEALTH-BUILDER

NANO CHAMPS (DEEPLY UNDERVALUED & UNDISCOVERED MICRO CAPS)

PAST PERFORMANCE >>> HIDDEN GEMS, VALUE PICKS & WEALTH-BUILDER >>>  VIEW / DOWNLOAD

SARAL GYAN ANNUAL SUBSCRIPTION SERVICES

Friday, October 1, 2010

15% @ 90 DAYS is Bang on Target in Just 7 Days

Dear Readers,

It gives us immense pleasure to inform you that our 15% @ 90 DAYS - September 2010 recommendation is bang on target in just 7 days and gave returns of almost 30% from our recommended price. We released 15% @ 90 DAYS report on 23rd september and mailed it to all our subscribers availing this service.

Based on technical as well as fundamental analysis, Saral Gyan equity analysts recommended Orchid Chemical & Pharmaceutical at a price of 207.65 on 23rd Sept 2010. Target price mentioned in the recommendation report was 245.50 with an upside potential of 18.2% over a period of 90 days. 

We are delighted to share that Orchid Chemical & Pharmaceuticals stock has closed today at 267.30, giving returns of 28.7% in a short span of just 7 days. As stock has already hit the recommended target price, we suggest our paid subscribers to book profits on this counter. Stock had a decent run up in last 2 days and already achieved our target price.

As stock is bang on target, we have made the report public. Our free subscribers and readers can download 15% @ 90 DAYS - September 2010 using below link. The report is also available at our website under Research Report section.

Photobucket

Its our mission to create wealth for our investors by providing them sound and unbiased stock research reports and recommendation based on fundamental and technical analysis.

Saral Gyan offers Hidden Gems, Value Picks & 15% IN 90 DAYS annual subscription services. To know more about subscription charges, click here!

Regards,

Equity Desk.
Saral Gyan Capital Services